ClinicalTrials.gov record
Not listed Phase 3 Interventional

A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma

ClinicalTrials.gov ID: NCT00002318

Public ClinicalTrials.gov record NCT00002318. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 6:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Adriamycin, Bleomycin, and Vincristine (ABV) in the Treatment of Severe AIDS-Related Kaposi's Sarcoma

Study identification

NCT ID
NCT00002318
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sequus Pharmaceuticals
Industry
Enrollment
225 participants

Conditions and interventions

Interventions

  • Bleomycin sulfate Drug
  • Doxorubicin hydrochloride Drug
  • Doxorubicin hydrochloride (liposomal) Drug
  • Vincristine sulfate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
28
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
East Bay AIDS Ctr Berkeley California 94705
Pacific Oaks Med Group Beverly Hills California 90211
Hematology - Oncology Med Group of San Fernando Valley Encino California 91436
Dr Becky Miller Los Angeles California 90048
Apogee Med Group San Diego California 92103
UCSF - San Francisco Gen Hosp San Francisco California 94110
Kaiser Permanente Med Ctr San Francisco California 94115
UCSF San Francisco California 94117
San Francisco Veterans Administration Med Ctr San Francisco California 94121
UCSF San Francisco California 941430324
Pacific Oaks Med Group Sherman Oaks California 91403
Dr Mahmoud Mustafa Washington D.C. District of Columbia 20037
Univ of Miami School of Medicine Miami Florida 33136
H Lee Moffit Cancer Ctr and Research Institute Tampa Florida 33612
American Med Research Institute Atlanta Georgia 30329
Infectious Disease Rsch Consortium of GA / SE Clin Resources Atlanta Georgia 30345
Northwestern Med Faculty Foundation Chicago Illinois 60611
Rush Presbyterian Med College Chicago Illinois 60612
Illinois Masonic Med Ctr / The Cancer Ctr Chicago Illinois 60657
Henry Ford Hosp Detroit Michigan 48202
Washington Univ St Louis Missouri 63108
Roswell Park Cancer Institute Buffalo New York 14263
Saint Vincent's Hosp and Med Ctr New York New York 10011
New York Univ Med Ctr New York New York 10016
Saint Luke's - Roosevelt Hosp Ctr New York New York 10023
Graduate Hosp / Tuttleman Cancer Ctr Philadelphia Pennsylvania 19146
Comprehensive Care Ctr Dallas Texas 75235
Baylor College of Medicine Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002318, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002318 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →